<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>Integrating phenotype ontologies with PhenomeNET</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Miguel Angel Rodr guez Garc a</string-name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Georgios V Gkoutos</string-name>
          <email>g.gkoutos@bham.ac.uk</email>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Paul N Scho eld</string-name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Robert Hoehndorf</string-name>
          <email>robert.hoehndorfg@kaust.edu.sa</email>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, Centre for Computational Biology, University of Birmingham</institution>
          ,
          <addr-line>Birmingham, B15 2TT</addr-line>
          ,
          <country country="UK">UK</country>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>Computational Bioscience Research Center, King Abdullah University of Science and Technology</institution>
          ,
          <addr-line>Thuwal 23955-6900, KSA</addr-line>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution>Department of Physiology, Development &amp; Neuroscience, University of Cambridge</institution>
          ,
          <addr-line>Downing Street, Cambridge, CB2 3EG</addr-line>
          ,
          <country country="UK">UK</country>
        </aff>
      </contrib-group>
      <abstract>
        <p>PhenomeNET is a system for disease gene prioritization that includes as one of its components an ontology designed to integrate phenotype ontologies. While not applicable to matching arbitrary ontologies, PhenomeNET can be used to identify related phenotypes in di erent species, including human, mouse, zebra sh, nematode worm, fruit y, and yeast. Here, we apply the PhenomeNET to identify related classes from four phenotype and disease ontologies using automated reasoning. We demonstrate that we can identify a large number of mappings, some of which require automated reasoning and cannot easily be identi ed through lexical approaches alone.</p>
      </abstract>
      <kwd-group>
        <kwd>PhenomeNET</kwd>
        <kwd>phenotype ontology</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>-</title>
      <p>1.1</p>
    </sec>
    <sec id="sec-2">
      <title>State, purpose, general statement</title>
      <p>PhenomeNET [1] was built in 2011 as a system for disease gene discovery
and prioritization. PhenomeNET consists of an ontology integrating
speciesspeci c phenotype ontologies based on the PATO ontology [2] and relations
between anatomical structures and physiological processes, a database of
gene-tophenotype associations, and a measure of similarity between sets of phenotypes.
Within PhenomeNET, species-speci c phenotype ontologies are combined so
that phenotypes observed in di erent species can be compared directly. The main
application of PhenomeNET is the prioritization of candidate genes for human
diseases by comparing human disease phenotypes to existing gene-phenotype
associations derived from model organisms. In particular, human phenotypes
associated with a disease can be compared to phenotypes observed in mouse or
other model organisms using the integrated PhenomeNET ontology, and
similarity between phenotypes can then be used to indicate the genetic basis of a
disease. PhenomeNET has been successfully used to nd candidate genes for
diseases [1, 3], identify novel pathways [4], and repurpose drugs using mouse model
phenotypes [5, 6].</p>
      <p>Here, we use the PhenomeNET ontology to identify alignments between
phenotypes in di erent species. We present three versions of the PhenomeNET
ontology; the rst version consists of the plain ontology using only the axioms
provided in the Human Phenotype Ontology (HPO) [7] and the Mammalian
Phenotype Ontology (MP) [8]; the second version uses additional lexical
mappings and represents them as equivalent class axioms in the ontology; the third
version further uses mappings generated by the AgreementMakerLight [9] to
generate equivalent class axioms between classes in the PhenomeNET ontology
and the Disease Ontology (DO) [10] and the Orphanet Rare Disease Ontology
(ORDO) [11].
1.2</p>
    </sec>
    <sec id="sec-3">
      <title>Speci c techniques used</title>
      <p>Phenotype classes in the HP and MP ontologies are formally de ned using the
Entity-Quality (EQ) pattern [2, 12]. Based on the EQ patterns, a phenotype is
decomposed into an a ected entity and a quality that speci es how the entity
is a ected. The Entity will usually be a class taken either from an anatomy
ontology or a physiology ontology. For example, the phenotype class macroglossia
(HP:0000158) describes an anatomical abnormality and is de ned as equivalent
to 'has part' some ('increased size' and ('inheres in' some tongue)
and ('has modifier' some abnormal)), relying on the entity tongue (from
the UBERON anatomy ontology) and the quality increased size (from PATO) in
its de nition. The class abnormality of salivation (HP:0100755) is a
physiological abnormality and is de ned as equivalent to 'has part' some (quality and
('inheres in' some 'saliva secretion') and ('has modifier' some abnormal)),
where saliva secretion is a class from the biological process branch of the GO.</p>
      <p>The general pattern for de ning a phenotype class in both the HP and MP
ontologies, given Entity E and Quality Q, is to declare them equivalent to 'has
part' some (Q and 'inheres in' some E). In some cases, the Entity E is
further constrained, e.g., by a location in which a certain process may happen. The
\E" classes are generally taken either from the UBERON cross-species anatomy
ontology [13] or from the GO. As the use of anatomy and physiology ontologies
(UBERON and GO) is shared between MP and HP, it should be possible to
integrate both ontologies directly, based on the axiom patterns used to constrain
their classes. However, the type of axiom pattern used in both ontologies results
in a classi cation that is primarily based on the PATO ontology, as the Quality
Q is the main feature that distinguishes di erent classes.</p>
      <p>In the PhenomeNET ontology, we rewrite all axioms in HP and MP using
a pattern-based approach that allows us to utilize axioms from anatomy and
physiology ontologies and enrich the classi cation of phenotype classes [14]. In
general, we declare phenotype classes de ned using an Entity E and Quality
Q as equivalent to 'has part' some (E and has-quality some Q) and we
further add grouping classes that are de ned as equivalent to 'has part' some
(('part of' some E) and has-quality some Q). The aim of rewriting the
axioms is to base the classi cation of phenotype classes primarily on anatomical
or physiological entities instead of the quality, and to utilize the axioms involving
parthood in anatomy and physiology ontologies. Crucially, all axioms we generate
fall in the OWL 2 EL pro le [15]. The rst version of the PhenomeNET ontology
(PhenomeNET-Plain) consists only of these axioms and no additional mappings.</p>
      <p>In addition to this knowledge-based approach to linking the HP and MP
ontologies, we also add lexical mappings, mappings derived from cross-references
in the ontologies [3], and mappings between HP and MP from BioPortal [16].
Each mapping is added as a single equivalent classes axiom to the rst version
of the ontology (PhenomeNET-Plain) to generate a version of the PhenomeNET
ontology with mappings (PhenomeNET-Map).</p>
      <p>Neither version of these ontologies contains the DO or ORDO ontologies,
despite there being a signi cant overlap between the four ontologies. Since
neither DO nor ORDO contain axioms that follow a similar pattern to the axioms
in HP and MP, we rely exclusively on lexical mappings to integrate DO and
ORDO. We use the AgreementMaker Light (AML) [9] in its default settings to
generate mappings between HP and DO, HP and ORDO, MP and DO, MP and
ORDO, and DO and ORDO. We then add an equivalent class axiom for each
mapping AML identi es and that has a score by AML over greater than 0:7.
The resulting ontology contains HP, MP, ORDO, and DO, and can be used to
generate mappings between these ontologies.</p>
      <p>All versions of the PhenomeNET ontology contain the classes from the HP
and MP ontologies as well as the subclass axioms between named classes
asserted in these ontologies. Furthermore, the PhenomeNET ontology imports
the ChEBI [17] and Mouse Pathology [18] ontologies using an OWL import
statement. Additionally, PhenomeNET includes all classes from the UBERON
anatomy ontology [13], the Gene Ontology [19], the BioSpatial Ontology [20],
the Zebra sh Anatomy ontology [21], the PATO ontology [2], the Cell Ontology
[22], and the Neuro-Behavior Ontology [23]. However, these ontologies are not
directly imported but rather pre-processed so that all disjointness axioms from
these ontologies are excluded while all other axioms contained within them are
included in the PhenomeNET ontology. The aim of this pre-processing step is to
avoid unsatis able classes due to di erent conceptualizations between anatomy
and phenotype ontologies, or within anatomy ontologies (Zebra sh Anatomy and
UBERON).</p>
      <p>Mappings between ontologies included in PhenomeNET are generated using
the ELK reasoner [24]. We use ELK to classify the PhenomeNET ontology and
identify pairs of equivalent classes C1 and C2 that belong to the ontologies to
be aligned. These constitute equivalent class mappings. Furthermore, subclass
and superclass mappings are generated through queries for sub- and superclasses
using ELK.</p>
      <p>Ontology
HP-MP
HP-MP+mappings
HP-MP+DO-ORDO
Within PhenomeNET, we use an ontology consisting only of the (rewritten)
axioms in MP and HP as well as equivalent class axioms derived from explicit
mappings between HP and MP (expressed as xref annotation properties). For
the evaluation, we further used the AML [9] to generate additional mappings.
The AML mappings were generated using the default settings of AML with a
con dence cuto of 0:7. In the case of DOID and ORDO mappings we
additionally included 18 mappings derived from BioPortal. Our systems relying on these
mappings were submitted as separate submissions.</p>
      <p>Initially, we developed our matching system to take into account not only
the direct sub- and super-classes, but also all inferred classes. We modi ed our
system to output only the most speci c mappings instead for the evaluation;
Table 2 shows both the number of direct and inferred mappings.
Our submission consists of two modules: PhenomeNetBridge and
PhenomeNetMatcher. The PhenomeNetBridge module wraps the SEALS infrastructure for
the evaluation, and the PhenomeNetMatcher module performs the mappings,
using one of three ontologies. Source code for the matching system, including
parameter les, and the generated alignments, are available at
http://github.com/bioontology-research-group/OAEI2016. Code to generate the PhenomeNET
ontology is available at
https://github.com/bio-ontology-research-group/phenomeblast/tree/master/ xphenotypes.</p>
      <sec id="sec-3-1">
        <title>Results</title>
      </sec>
    </sec>
    <sec id="sec-4">
      <title>Phenotype ontologies: HP and MP</title>
      <p>The PhenomeNET ontology is primarily intended to integrate the HP and MP
ontologies. Using the axioms in the ontology alone (PhenomeNET-Plain
submission), we identify 745 equivalent classes between the HP and MP ontologies
(see Table 2). These correspond to a recall of 40.8% with respect to the
reference mappings provided (see Table 3). Additionally, a large number of sub- and
super-class mappings can be identi ed based on querying the ontology using the
ELK reasoner [24] for sub- or super-classes in the two ontologies.</p>
      <p>The number of pairs of equivalent classes identi ed increases to 1,536 when
adding explicit mappings derived from AML. Of these, 370 are generated both by
automated reasoning and are included in AML, 791 are generated from the
AMLderived equivalent classes axioms, and 375 could only be derived through the
automated reasoning. Total recall with respect to the reference mappings is 100%
in this version of PhenomeNET. Additionally, we observe an improvement in the
number of equivalent class mappings when adding the ORDO and DO ontologies
to the PhenomeNET ontology. The increase in mappings (from 1,536 to 1,582
classes) is a result of additional inferences obtained from adding the mappings
from HP and MP to ORDO and DO, and combining them with the axioms in the
PhenomeNET ontology. For example, we infer a new mapping between decreased
IgG level (MP:0001805) and agammaglobulinemia (HP:0004432) based on the
equivalence axioms between both classes and agammaglobulinemia (DOID:2583)
generated by AML (based on the shared synonym \hypogammaglobulinemia"
between the class in DO and MP). Table 3 summarizes our results with respect
to the reference mappings provided in the challenge.
2.2</p>
    </sec>
    <sec id="sec-5">
      <title>Disease ontologies: ORDO and DO</title>
      <p>PhenomeNET is primarily designed for ontologies that follow the Entity-Quality
de nition pattern based on the PATO ontology. Neither ORDO nor DO follow
this pattern, and ORDO and DO are primarily included in the PhenomeNET
ontology through equivalent class axioms based on lexical mappings generated
by AML. We achieve a recall of 99.9% with the PhenomeNET-Full ontology.
Notably, the mappings we generate are increased by including HP and MP. For
example, we identify a mapping between mandibulofacial dysostosis (ORPHANET:155899)
and treacher collins syndrome (DOID:2908), based on common AML-generated
mappings to mandibulofacial dysostosis (HP:0005321).
2.3</p>
    </sec>
    <sec id="sec-6">
      <title>OAEI evaluation</title>
      <p>In order to carry out the nal evaluation, the OAEI utilized the SEALS
infrastructure executed in a Ubuntu Laptop with an Intel Core i7-4600U CPU @
2.10GHz x 4 and allocating 15Gb of RAM. The system carried out the evaluation
according to following criteria:
{ Precision and Recall with respect to a voted reference alignment
automatically generated by merging/voting the outputs of the participating systems.
{ Recall with respect to alignment manually generated.
{ Manual assesment of a subset of generating mappings.
{ Performance in other tracks.</p>
      <p>Di erent mappings were used to evaluate the participating systems: i) Silver
standard with vote 2, ii) Silver standard with vote 3, iii) manually dataset and
manual assessment. In the rst dataset, PhenomeNET including all mappings
reached an F-measure of 0:82 in the HP-MP task, and 0:89 in the DO-ORDO
task. In the second evaluation, although the system PhenoMP was able to nd
the largest number of mappings in HP-MP task, it reached an F-measure of 0:76
in the HP-MP task and 0:94 in the DO-ORDO task. When evaluating against
manually created mappings, PhenomeNET achieved a recall of 0:897 in the
HPMP task but could not generate any new mappings between DO and ORDO. For
this task, PhenomeNET achieved a precision of 1:0 in the manual assessment of
a subset of the generated mappings.
3
3.1</p>
      <sec id="sec-6-1">
        <title>General comments</title>
      </sec>
    </sec>
    <sec id="sec-7">
      <title>Comments on the results</title>
      <p>PhenomeNET is a system to match phenotypes; as such, it is not a system
that can be applied to match ontologies in general. The axiom-based approach
in PhenomeNET can be applied to any ontologies that utilize PATO and the
Entity-Quality de nition patterns [2]. In particular, PhenomeNET can not only
be used to integrate MP and HPO, but also has been used to further integrate
yeast, y, worm, slime mold, and sh phenotypes [1, 25]. Furthermore, the
combination of semantic matching (using automated reasoning) and lexical matching
in PhenomeNET mitigates some of the limitations of using lexical approaches
alone, and we demonstrate this by inferring several hundred mappings between
HP and MP that cannot be inferred using AML.</p>
      <p>However, relying on manually created axioms also has several limitations.
In particular, the axioms are created by domain experts, and only about half
the classes in MP and HP are constrained by an Entity-Quality based axiom.
Furthermore, the quality of the axioms is di cult to assess, and there are distinct
di erences between HP and MP in how the classes are constrained.
3.2</p>
    </sec>
    <sec id="sec-8">
      <title>Discussions on the way to improve the proposed system</title>
      <p>One of the main limitations in PhenomeNET is the need for manually created
axioms that constrain classes in phenotype ontologies. A possible solution to
this approach would be to generate phenotype ontologies fully automatically
using anatomy and physiology ontologies as templates and applying the axiom
patterns we use in the PhenomeNET [26].</p>
      <p>Another limitation of PhenomeNET is the reliance on OWL 2 EL which limits
the expressivity of axiom patterns. The choice is mainly due to the size of the
PhenomeNET ontology and the complexity of reasoning. However, more complex
axiom patterns would enable more comprehensive classi cation of phenotypes
involving absences and abnormalities [14]; experiments with an updated ontology
will likely require improvement in OWL reasoning technologies.
4</p>
      <sec id="sec-8-1">
        <title>Conclusions</title>
        <p>
          We have developed an ontology matching system for disease and phenotype
ontologies. We generated three di erent version of the PhenomeNet ontology, each
with di erent information and ontologies included. PhenomeNET is primarily
based on deductive inference and automated reasoning, and while it can utilize
lexically derived mappings in the ontology generation process, it does not on
its own include any lexical matching algorithms. Our results demonstrate that
a combination of lexical and semantic approaches may improve upon mappings
between ontologies generated using only one of these methods.
7. Kohler, S., Doelken, S.C., Mungall, C.J., Bauer, S., Firth, H.V., Bailleul-Forestier,
I., Black, G.C.M., Brown, D.L., Brudno, M., Campbell, J., FitzPatrick, D.R.,
Eppig, J.T., Jackson, A.P., Freson, K., Girdea, M., Helbig, I., Hurst, J.A., Jahn, J.,
Jackson, L.G., Kelly, A.M., Ledbetter, D.H., Mansour, S., Martin, C.L., Moss, C.,
Mumford, A., Ouwehand, W.H., Park, S.M., Riggs, E.R., Scott, R.H., Sisodiya,
S., Vooren, S.V., Wapner, R.J., Wilkie, A.O.M., Wright, C.F., Vulto-van Silfhout,
A.T., Leeuw, N.d., de Vries, B.B.A., Washingthon, N.L., Smith, C.L., Wester eld,
M., Scho eld, P., Ruef, B.J., Gkoutos, G.V., Haendel, M., Smedley, D., Lewis, S.E.,
Robinson, P.N.: The human phenotype ontology project: linking molecular biology
and disease through phenotype data. Nucleic Acids Res 42(D1) (2014) D966{D974
8. Smith, C.L., Goldsmith, C.A.W., Eppig, J.T.: The mammalian phenotype ontology
as a tool for annotating, analyzing and comparing phenotypic information. Genome
Biol 6(
          <xref ref-type="bibr" rid="ref1">1</xref>
          ) (2004) R7 DOI:10.1186/gb-2004-6-1-r7.
9. Faria, D., Pesquita, C., Santos, E., Palmonari, M., Cruz, I.F., Couto, F.M. In:
The AgreementMakerLight Ontology Matching System. Springer Berlin
Heidelberg, Berlin, Heidelberg (2013) 527{541
10. Kibbe, W.A., Arze, C., Felix, V., Mitraka, E., Bolton, E., Fu, G., Mungall, C.J.,
Binder, J.X., Malone, J., Vasant, D., Parkinson, H., Schriml, L.M.: Disease
ontology 2015 update: an expanded and updated database of human diseases for
linking biomedical knowledge through disease data. Nucleic Acids Res 43 (2014)
D1071{D1078
11. Sarntivijai, S., Vasant, D., Jupp, S., Saunders, G., Bento, A.P., Gonzalez, D.,
Betts, J., Hasan, S., Koscielny, G., Dunham, I., Parkinson, H., Malone, J.: Linking
rare and common disease: mapping clinical disease-phenotypes to ontologies in
therapeutic target validation. Journal of Biomedical Semantics 7(
          <xref ref-type="bibr" rid="ref1">1</xref>
          ) (2016) 1{11
12. Mungall, C., Gkoutos, G., Smith, C., Haendel, M., Lewis, S., Ashburner, M.:
Integrating phenotype ontologies across multiple species. Genome Biol 11(
          <xref ref-type="bibr" rid="ref1">1</xref>
          ) (2010)
R2+
13. Mungall, C., Torniai, C., Gkoutos, G., Lewis, S., Haendel, M.: Uberon, an
integrative multi-species anatomy ontology. Genome Biology 13(
          <xref ref-type="bibr" rid="ref1">1</xref>
          ) (2012) R5
14. Hoehndorf, R., Oellrich, A., Rebholz-Schuhmann, D.: Interoperability between
phenotype and anatomy ontologies. Bioinformatics 26(24) (10 2010) 3112 { 3118
15. Motik, B., Grau, B.C., Horrocks, I., Wu, Z., Fokoue, A., Lutz, C.: Owl 2 web
ontology language: Pro les. Recommendation, World Wide Web Consortium (W3C)
(2009)
16. Noy, N.F., Shah, N.H., Whetzel, P.L., Dai, B., Dorf, M., Gri th, N., Jonquet, C.,
Rubin, D.L., Storey, M.A.A., Chute, C.G., Musen, M.A.: Bioportal: ontologies and
integrated data resources at the click of a mouse. Nucleic acids research 37(Web
Server issue) (July 2009) W170{173
17. Degtyarenko, K., Matos, P., Ennis, M., Hastings, J., Zbinden, M., McNaught, A.,
Alcantara, R., Darsow, M., Guedj, M., Ashburner, M.: ChEBI: a database and
ontology for chemical entities of biological interest. Nucleic Acids Research (2007)
18. Scho eld, P.N., Sundberg, J.P., Sundberg, B.A., McKerlie, C., Gkoutos, G.V.: The
mouse pathology ontology, mpath; structure and applications. Journal of
Biomedical Semantics 4(
          <xref ref-type="bibr" rid="ref1">1</xref>
          ) (2013) 1{8
19. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, M.J.,
Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T., Harris, M.A., Hill, D.P.,
Tarver, L.I., Kasarskis, A., Lewis, S., Matese, J.C., Richardson, J.E., Ringwald,
M., Rubin, G.M., Sherlock, G.: Gene ontology: tool for the uni cation of biology.
        </p>
        <p>
          Nature Genetics 25(
          <xref ref-type="bibr" rid="ref1">1</xref>
          ) (May 2000) 25{29
20. Balho , J.P., Mik, I., Yoder, M.J., Mullins, P.L., Deans, A.R.: A semantic model
for species description applied to the ensign wasps (hymenoptera: Evaniidae) of
new caledonia. Systematic Biology 62(
          <xref ref-type="bibr" rid="ref5">5</xref>
          ) (2013) 639{659
21. Dahdul, W.M., Balho , J.P., Engeman, J., Grande, T., Hilton, E.J., Kothari, C.,
Lapp, H., Lundberg, J.G., Midford, P.E., Vision, T.J., Wester eld, M., Mabee,
P.M.: Evolutionary characters, phenotypes and ontologies: curating data from the
systematic biology literature. PLoS One 5(
          <xref ref-type="bibr" rid="ref5">5</xref>
          ) (2010) e10708
22. Bard, J., Rhee, S.Y., Ashburner, M.: An ontology for cell types. Genome Biology
6(
          <xref ref-type="bibr" rid="ref2">2</xref>
          ) (2005)
23. Hoehndorf, R., Hancock, J.M., Hardy, N.W., Mallon, A.M., Scho eld, P.N.,
Gkoutos, G.V.: Analyzing gene expression data in mice with the Neuro Behavior
Ontology. Mamm Genome 25(
          <xref ref-type="bibr" rid="ref1 ref2">1-2</xref>
          ) (2014) 32{40
24. Kazakov, Y., Krotzsch, M., Simancik, F.: The incredible elk. Journal of Automated
        </p>
        <p>
          Reasoning 53(
          <xref ref-type="bibr" rid="ref1">1</xref>
          ) (2014) 1{61
25. Hoehndorf, R., Hardy, N.W., Osumi-Sutherland, D., Tweedie, S., Scho eld, P.N.,
Gkoutos, G.V.: Systematic analysis of experimental phenotype data reveals gene
functions. PLoS ONE 8(
          <xref ref-type="bibr" rid="ref4">4</xref>
          ) (04 2013) e60847
26. Hoehndorf, R., Harris, M.A., Herre, H., Rustici, G., Gkoutos, G.V.: Semantic
integration of physiology phenotypes with an application to the cellular phenotype
ontology. Bioinformatics 28(13) (2012) 1783{1789
        </p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          1.
          <string-name>
            <surname>Hoehndorf</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          , Scho eld,
          <string-name>
            <given-names>P.N.</given-names>
            ,
            <surname>Gkoutos</surname>
          </string-name>
          ,
          <string-name>
            <surname>G.V.</surname>
          </string-name>
          :
          <article-title>Phenomenet: a whole-phenome approach to disease gene discovery</article-title>
          .
          <source>Nucleic Acids Res</source>
          <volume>39</volume>
          (
          <issue>18</issue>
          ) (
          <year>2011</year>
          ) e119
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          2.
          <string-name>
            <surname>Gkoutos</surname>
            ,
            <given-names>G.V.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Green</surname>
            ,
            <given-names>E.C.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Mallon</surname>
            ,
            <given-names>A.M.M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Hancock</surname>
            ,
            <given-names>J.M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Davidson</surname>
            ,
            <given-names>D.</given-names>
          </string-name>
          :
          <article-title>Using ontologies to describe mouse phenotypes</article-title>
          .
          <source>Genome biology 6(1)</source>
          (
          <year>2005</year>
          ) R5
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          3.
          <string-name>
            <surname>Hoehndorf</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          , Scho eld,
          <string-name>
            <given-names>P.N.</given-names>
            ,
            <surname>Gkoutos</surname>
          </string-name>
          ,
          <string-name>
            <surname>G.V.</surname>
          </string-name>
          :
          <article-title>An integrative, translational approach to understanding rare and orphan genetically based diseases</article-title>
          .
          <source>Interface Focus</source>
          <volume>3</volume>
          (
          <issue>2</issue>
          ) (
          <year>2013</year>
          )
          <fpage>20120055</fpage>
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          4.
          <string-name>
            <surname>Hoehndorf</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Dumontier</surname>
            ,
            <given-names>M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Gkoutos</surname>
            ,
            <given-names>G.V.</given-names>
          </string-name>
          :
          <article-title>Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics</article-title>
          .
          <source>Bioinformatics</source>
          <volume>28</volume>
          (
          <issue>16</issue>
          ) (
          <year>2012</year>
          )
          <volume>2169</volume>
          {
          <fpage>2175</fpage>
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          5.
          <string-name>
            <surname>Hoehndorf</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Oellrich</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Rebholz-Schuhmann</surname>
            ,
            <given-names>D.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Scho</surname>
            <given-names>eld</given-names>
          </string-name>
          ,
          <string-name>
            <given-names>P.N.</given-names>
            ,
            <surname>Gkoutos</surname>
          </string-name>
          ,
          <string-name>
            <surname>G.V.</surname>
          </string-name>
          :
          <article-title>Linking PharmGKB to phenotype studies and animal models of disease for drug repurposing</article-title>
          .
          <source>Paci c Symposium on Biocomputing (PSB)</source>
          (
          <year>2012</year>
          )
          <volume>388</volume>
          {
          <fpage>399</fpage>
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          6.
          <string-name>
            <surname>Hoehndorf</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Hiebert</surname>
            ,
            <given-names>T.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Hardy</surname>
            ,
            <given-names>N.W.</given-names>
          </string-name>
          , Scho eld,
          <string-name>
            <given-names>P.N.</given-names>
            ,
            <surname>Gkoutos</surname>
          </string-name>
          ,
          <string-name>
            <given-names>G.V.</given-names>
            ,
            <surname>Dumontier</surname>
          </string-name>
          ,
          <string-name>
            <surname>M.</surname>
          </string-name>
          :
          <article-title>Mouse model phenotypes provide information about human drug targets</article-title>
          .
          <source>Bioinformatics</source>
          <volume>30</volume>
          (
          <issue>5</issue>
          ) (
          <year>2014</year>
          )
          <volume>719</volume>
          {
          <fpage>725</fpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>